PA
Probity Advisors’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-938
| Closed | -$217K | – | 228 |
|
|
2024
Q2 | $217K | Buy |
+938
| New | +$217K | 0.05% | 197 |
|
|
2023
Q3 | – | Sell |
-708
| Closed | -$202K | – | 181 |
|
|
2023
Q2 | $202K | Buy |
+708
| New | +$202K | 0.04% | 186 |
|
|
2022
Q4 | $205K | Sell |
741
-22
| -3% | -$6.09K | 0.05% | 175 |
|
|
2022
Q3 | $204K | Buy |
+763
| New | +$204K | 0.05% | 167 |
|
|
2022
Q1 | – | Sell |
-958
| Closed | -$230K | – | 187 |
|
|
2021
Q4 | $230K | Sell |
958
-429
| -31% | -$103K | 0.05% | 181 |
|
|
2021
Q3 | $393K | Buy |
1,387
+10
| +0.7% | +$2.83K | 0.08% | 154 |
|
|
2021
Q2 | $477K | Buy |
1,377
+50
| +4% | +$17.3K | 0.1% | 134 |
|
|
2021
Q1 | $371K | Buy |
+1,327
| New | +$371K | 0.08% | 147 |
|
|
2020
Q3 | $348K | Sell |
1,226
-20
| -2% | -$5.68K | 0.1% | 139 |
|
|
2020
Q2 | $333K | Sell |
1,246
-26
| -2% | -$6.95K | 0.1% | 138 |
|
|
2020
Q1 | $402K | Sell |
1,272
-44
| -3% | -$13.9K | 0.15% | 117 |
|
|
2019
Q4 | $390K | Sell |
1,316
-92
| -7% | -$27.3K | 0.12% | 134 |
|
|
2019
Q3 | $328K | Buy |
1,408
+163
| +13% | +$38K | 0.11% | 139 |
|
|
2019
Q2 | $291K | Buy |
1,245
+138
| +12% | +$32.3K | 0.1% | 151 |
|
|
2019
Q1 | $262K | Buy |
1,107
+39
| +4% | +$9.23K | 0.09% | 150 |
|
|
2018
Q4 | $321K | Sell |
1,068
-26
| -2% | -$7.82K | 0.12% | 133 |
|
|
2018
Q3 | $387K | Buy |
1,094
+20
| +2% | +$7.08K | 0.13% | 122 |
|
|
2018
Q2 | $312K | Buy |
1,074
+63
| +6% | +$18.3K | 0.11% | 130 |
|
|
2018
Q1 | $277K | Buy |
1,011
+133
| +15% | +$36.4K | 0.1% | 137 |
|
|
2017
Q4 | $280K | Buy |
878
+73
| +9% | +$23.3K | 0.1% | 134 |
|
|
2017
Q3 | $252K | Buy |
805
+37
| +5% | +$11.6K | 0.09% | 127 |
|
|
2017
Q2 | $208K | Buy |
+768
| New | +$208K | 0.08% | 135 |
|